Atossa Therapeutics
ATOS
#10504
Rank
NZ$34.91 M
Marketcap
NZ$3.50
Share price
1.26%
Change (1 day)
164.18%
Change (1 year)

Earnings for Atossa Therapeutics (ATOS)

Earnings in 2025 (TTM): -NZ$51.93 Million

According to Atossa Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -NZ$44.42 Million, an increase over its 2023 earnings that were of -NZ$52.41 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atossa Therapeutics from 2011 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$51.93 Million16.9%
2024 -NZ$44.42 Million-15.25%
2023 -NZ$52.41 Million11.62%
2022 -NZ$46.96 Million30.84%
2021 -NZ$35.89 Million15.58%
2020 -NZ$31.05 Million3.41%
2019 -NZ$30.03 Million51.16%
2018 -NZ$19.87 Million40.41%
2017 -NZ$14.15 Million27.54%
2016 -NZ$11.1 Million-47.49%
2015 -NZ$21.13 Million-17.25%
2014 -NZ$25.53 Million35.91%
2013 -NZ$18.79 Million112.3%
2012 -NZ$8.85 Million46.53%
2011 -NZ$6.04 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$45.24 B-86,180.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
NZ$2.39 B-4,659.31%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$2.39 B-4,656.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
NZ$72.58 M-238.11%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-NZ$0.18 Billion 229.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-NZ$13.66 Million-74.02%๐Ÿ‡บ๐Ÿ‡ธ USA